Long-term safety and efficacy of TAK-861 in individuals with narcolepsy type 1: Results from an interim analysis of a dose-blinded extension study

Category Primary study
Conference27th Congress of the European Sleep Research Society
Year 2024
This article has no abstract
Epistemonikos ID: 594e7aac8d35460857b26ad7818fa611905a7057
First added on: Jan 10, 2026